Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery
Clinical trial NCT04233073 · TERMINATED
Trial details
- NCT number
- NCT04233073
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-27
- Primary completion
- 2021-11-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.